3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
11
Nasopharyngeal Carcinoma
6
Oropharyngeal Neoplasms
5
Prostatic Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma
4
Mouth Neoplasms
3
Hypopharyngeal Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mesothelioma
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Anus Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Mesothelioma, Malignant
1
Meningioma
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced Cervical Adenocarcinoma
1
HIV Infections
1
Glioma
1
Glioblastoma
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Biopsy
7
pembrolizumab
6
Doxorubicin
6
Cyclophosphamide
6
X-Rays
4
Radiation
4
Phantoms, Imaging
4
Radiotherapy
3
Nuclear Medicine Department, Hospital
3
Irinotecan
3
Ifosfamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pazopanib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
fludarabine
2
ensartinib
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.